The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis
Open accessAbstract
The mechanisms underlying the susceptibility of individuals with caspase recruitment domain 15 (CARD15) mutations and corresponding abnormalities of nucleotide-binding oligomerization domain 2 (NOD2) protein to Crohn disease are still poorly understood. One possibility is based on previous studies showing that muramyl dipeptide (MDP) activation of NOD2 negatively regulates TLR2 responses and that absence of such regulation leads to heightened Th1 responses. We now report that administration of MDP protects mice from the development of experimental colitis by downregulating multiple TLR responses, not just TLR2. The basis of these in vivo findings was suggested by in vitro studies of DCs, in which we showed that prestimulation of cells with MDP reduces cytokine responses to multiple TLR ligands and this reduction is dependent on enhanced IFN regulatory factor 4 (IRF4) activity. Further studies of mouse models of colitis showed that this inhibitory role of IRF4 does in fact apply to MDP-mediated protection from colitis, since neither IRF4-deficient mice nor mice treated with siRNA specific for IRF4 were protected. These findings indicate that MDP activation of NOD2 regulates innate responses to intestinal microflora by downregulating multiple TLR responses and suggest that the absence of such regulation leads to increased susceptibility to Crohn disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,408
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., & Flavell, R. A. (2005) · Science · doi:10.1126/science.1104911 · Cited by 1,776
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Self-citationHost Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2
Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200673200 · Cited by 1,696
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Self-citationThe Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
Self-citationIRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells
Langenkamp, A., Messi, M., Lanzavecchia, A., & Sallusto, F. (2000) · Nature Immunology · doi:10.1038/79758 · Cited by 1,143
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Nuñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 991
Signalling pathways and molecular interactions of NOD1 and NOD2
Strober, W., Murray, P. J., Kitani, A., & Watanabe, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1747 · Cited by 856
Self-citationAnti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 848
Self-citationNOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses
Watanabe, T., Kitani, A., Murray, P. J., & Strober, W. (2004) · Nature Immunology · doi:10.1038/ni1092 · Cited by 840
Self-citationNod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 749
Interleukin 7 Regulates the Survival and Generation of Memory CD4 Cells
Kondrack, R. M., Harbertson, J., Tan, J. T., McBreen, M. E., Surh, C. D., & Bradley, L. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030735 · Cited by 471
Toll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 451
Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation
Gutierrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y., Prosper, F., Nuñez, G., & Fernandez-Luna, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206473200 · Cited by 444
Tamura, T., Tailor, P., Yamaoka, K., Kong, H. J., Tsujimura, H., O’Shea, J. J., Singh, H., & Ozato, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2573 · Cited by 423
Self-citationNegative regulation of Toll-like-receptor signaling by IRF-4
Negishi, H., Ohba, Y., Yanai, H., Takaoka, A., Honma, K., Yui, K., Matsuyama, T., Taniguchi, T., & Honda, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508327102 · Cited by 405
Defective acute inflammation in Crohn's disease: a clinical investigation
Marks, D. J., Harbord, M. W., MacAllister, R., Rahman, F. Z., Young, J., Al-Lazikani, B., Lees, W., Novelli, M., Bloom, S., & Segal, A. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68265-2 · Cited by 383
Tada, H., Aiba, S., Shibata, K.-I., Ohteki, T., & Takada, H. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.7967-7976.2005 · Cited by 366
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Rakoff-Nahoum, S., Hao, L., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.010 · Cited by 344
OBERMEIER, F., KOJOUHAROFF, G., HANS, W., SCHÖLMERICH, J., GROSS, V, & FALK, W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00878.x · Cited by 317
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
van Heel, D. A., Ghosh, S., Butler, M., Hunt, K. A., Lundberg, A. M., Ahmad, T., McGovern, D. P., Onnie, C., Negoro, K., Goldthorpe, S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66582-8 · Cited by 312
Netea, M. G., Ferwerda, G., de Jong, D. J., Jansen, T., Jacobs, L., Kramer, M., Naber, T. H. J., Drenth, J. P. H., Girardin, S. E., Jan Kullberg, B., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6518 · Cited by 273
Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists
Pauleau, A.-L., & Murray, P. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7531-7539.2003 · Cited by 260
Self-citationStaphylococcus aureus Peptidoglycan Is a Toll-Like Receptor 2 Activator: a Reevaluation
Dziarski, R., & Gupta, D. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5212-5216.2005 · Cited by 230
Watanabe, T., Kitani, A., Murray, P. J., Wakatsuki, Y., Fuss, I. J., & Strober, W. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.018 · Cited by 218
Self-citationUehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S., & Takada, H. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00433.x · Cited by 199
A Role for Erbin in the Regulation of Nod2-dependent NF-κB Signaling
McDonald, C., Chen, F. F., Ollendorff, V., Ogura, Y., Marchetto, S., Lécine, P., Borg, J.-P., & Nuñez, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508538200 · Cited by 178
Fichtner-Feigl, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24792 · Cited by 172
Honma, K., Udono, H., Kohno, T., Yamamoto, K., Ogawa, A., Takemori, T., Kumatori, A., Suzuki, S., Matsuyama, T., & Yui, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504226102 · Cited by 160
Gingras, S., Parganas, E., Pauw, A. D., Ihle, J. N., & Murray, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411043200 · Cited by 158
Self-citationActivation of toll-like receptor 3 protects against DSS-induced acute colitis
Vijay–Kumar, M., Wu, H., Aitken, J., Kolachala, V. L., Neish, A. S., Sitaraman, S. V., & Gewirtz, A. T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20142 · Cited by 139
Lehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 129
Uehori, J., Fukase, K., Akazawa, T., Uematsu, S., Akira, S., Funami, K., Shingai, M., Matsumoto, M., Azuma, I., Toyoshima, K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7096 · Cited by 98
Yang, Z., Fuss, I. J., Watanabe, T., Asano, N., Davey, M. P., Rosenbaum, J. T., Strober, W., & Kitani, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.07.025 · Cited by 91
Self-citationNOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn’s disease
Watanabe, T., Kitani, A., & Strober, W. (2005) · Gut · doi:10.1136/gut.2005.071795 · Cited by 74
Self-citationWatanabe, T., Yoshida, M., Shirai, Y., Yamori, M., Yagita, H., Itoh, T., Chiba, T., Kita, T., & Wakatsuki, Y. (2002) · Journal of Immunology · doi:10.4049/jimmunol.168.5.2188 · Cited by 60
Self-citationWatanabe, T., Katsukura, H., Shirai, Y., Yamori, M., Nishi, T., Chiba, T., Kita, T., & Wakatsuki, Y. (2003) · Hepatology · doi:10.1053/jhep.2003.50343 · Cited by 47
Self-citationToll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522996 · Cited by 44
Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4
Yoshida, K., Yamamoto, K., Kohno, T., Hironaka, N., Yasui, K., Kojima, C., Mukae, H., Kadota, J., Suzuki, S., Honma, K., et al. (2005) · International Immunology · doi:10.1093/intimm/dxh324 · Cited by 30
Anti-Interleukin-12 Antibody for Active Crohn’s disease
Lebiedz, P., & Kucharzik, T. F. (2005) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-858184 · Cited by 25
CD4+CD25+ T Cells Regulate Colonic Localization of CD4 T Cells Reactive to a Microbial Antigen
Watanabe, T., Yamori, M., Kita, T., Chiba, T., & Wakatsuki, Y. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000163696.26969.e4 · Cited by 14
Self-citation
Cited by
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
Chassaing, B., Aitken, J. D., Malleshappa, M., & Vijay‐Kumar, M. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1525s104 · Cited by 2,090
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940
Metadata
- Authors
- Watanabe, T., Asano, N., Murray, P. J., Ozato, K., Tailor, P., Fuss, I. J., Kitani, A., & Strober, W.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-10
- Volume
- 118
- Issue
- 2
- Pages
- 545-59
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2013475718
- Cited by
- 326
- References
- 46
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.